QMLGSep 10, 2023

Computational Approaches for Predicting Drug-Disease Associations: A Comprehensive Review

arXiv:2309.06388v141 citationsh-index: 12
Originality Synthesis-oriented
AI Analysis

It addresses the problem of high costs and inefficiencies in drug development for researchers and pharmaceutical industries, but is incremental as a review paper.

This paper reviews computational methods for predicting drug-disease associations to reduce costs and risks in drug development, comparing performance across categories like neural networks and matrix-based algorithms.

In recent decades, traditional drug research and development have been facing challenges such as high cost, long timelines, and high risks. To address these issues, many computational approaches have been suggested for predicting the relationship between drugs and diseases through drug repositioning, aiming to reduce the cost, development cycle, and risks associated with developing new drugs. Researchers have explored different computational methods to predict drug-disease associations, including drug side effects-disease associations, drug-target associations, and miRNAdisease associations. In this comprehensive review, we focus on recent advances in predicting drug-disease association methods for drug repositioning. We first categorize these methods into several groups, including neural network-based algorithms, matrixbased algorithms, recommendation algorithms, link-based reasoning algorithms, and text mining and semantic reasoning. Then, we compare the prediction performance of existing drug-disease association prediction algorithms. Lastly, we delve into the present challenges and future prospects concerning drug-disease associations.

Foundations

The foundational work for this paper's niche, ranked by how specifically the neighbourhood builds on it — not by global fame.

Your Notes